Akèy › Talasemi
Etid klinik pou Talasemi ap rekrite nan Etazini
7 etid pou Talasemi ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Ap rekriteFaz 1 bonè
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06313398ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
Ap rekriteFaz 1/2
Laj 18 a 40 · Tout sèks · Mizajou Sep 23, 2026 · NCT06364774A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06609226ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Ap rekriteFaz 2
Laj 2 a 50 · Tout sèks · Mizajou Jun 3, 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Ap rekriteFaz 3
Laj 12 a 35 · Tout sèks · Mizajou Mar 23, 2026 · NCT05477563Study of the Role of Genetic Modifiers in Hemoglobinopathies
Ap rekriteEtid obsèvasyon
Laj 2 ak plis · Tout sèks · Mizajou Mar 20, 2024 · NCT05799118Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.